iHF annual Course
20-21 March, 2026 - Madrid, Spain
Subtitle
Expert Insights
Title News & Resources
Explore our curated collection of recommended articles and past webinars, designed to keep you informed and inspired.
-
Myocardial dysfunction & atrial disordersAcute decompensated Heart Failureꓽ should the focus be solely on the heart?
-
News
Is there benefit from mid-to-high normal potassium levels in patients with an ICD?
-
News
ESC Congress 2025 – Late-breaking trial highlights
-
News
What is the role of mechanical circulatory support in decompensated heart failure?
-
Myocardial dysfunction & atrial disordersNovel fast-track strategies to guidelines-directed medical therapy optimisation in heart failure patients with functional mitral regurgitation
Recording TV Studio
-
Coronary artery disease Myocardial dysfunction & atrial disordersImproving Heart Function: trans-disciplinary innovative drugs and device solutions for heart failure care
Recording TV Studio
Subtitle
About
Title Trans-disciplinary innovation in heart failure drugs and device solutions to improve patient care
What is iHF?
Welcome to the Improving Heart Function (iHF) initiative, an innovative educational project dedicated to promoting comprehensive care for heart failure patients accross all specialties.
Our mission is to assemble a trans-disciplinary team to identify and address unmet needs in heart failure management. By enhancing the collaboration between pharmaceuticals and medical devices, we aim to optimise patient outcomes.
Our focus areas include:
- Healthcare management: Integrating lifelong management of drugs and devices to ensure the effective implementation of guideline-directed medical therapy.
- Patient management: Enhancing patient selection and risk stratification through advanced imaging and biomarkers, while addressing the challenges faced by patients with implanted devices.
This initiative is open to all healthcare professionals committed to the optimal management of heart failure patients. Whether you are a cardiologist, general practitioner, nephrologist, endocrinologist, intensivist, geriatrician, or primary care specialist, your expertise is highly valuable.
Join us in this global effort to transform and improve heart failure care.
Image
Title A word from our Steering Committee
Title Emanuele Barbato - Interview
01 September 2025
Title Giuseppe Rosano - Interview
01 September 2025
Subtitle
Our team
Title Steering Committee
-
Emanuele BarbatoInterventional cardiologistItaly -
Sabine BleizifferCardiac surgeonGermany -
Christophe LeclercqElectrophysiologistFrance -
Alexandre MebazaaAnaesthesiologistFrance -
Giuseppe RosanoCardiologistUnited Kingdom
Subtitle
Industry Partners
Title Support our initiative
Contenu
We extend our heartfelt gratitude to the industry partners who support the Improving Heart Function Initiative. Your commitment and collaboration are vital to our mission of advancing trans-disciplinary innovation in heart failure drugs and devices to improve patient care.
By partnering with us, you will join an initiative aimed at addressing unmet needs in heart failure management and advancing healthcare. We aim to work collaboratively to impact the lives of patients globally. Our focus areas include biomarkers, devices, HF management systems, imaging, and drug-oriented solutions.
Your support will help create educational tools and consensus messages on drug and device synergy for the trans-disciplinary worldwide community through webinars, articles, and tailored sessions at the iHF Annual Course.
For more information, please contact us at Ihf-organisation@europa-group.com
